doi: 10.1016/S0140-6736(20)30566-3 308 ZuoL.PratherE
Research shows its more effective than oral glutathione alone, boosting glutathione levels and improving markers of healthy aging
* Based on the trial product estimand: estimated efficacy in an idealized scenario in which all patients stayed on treatment and took no other weight loss therapies ** Based on the treatment policy estimand: estimated efficacy regardless of whether patients stayed on treatment or took other weight loss therapies About CagriSema CagriSema is being investigated by Novo Nordisk as a once-weekly subcutaneous injectable treatment for adults with overweight or obesity (REDEFINE program) and as a treatment for adults with type 2 diabetes (REIMAGINE program)

Benefits of GLP-1 Drugs Significant weight loss: Users often lose 10-15% of their body weight Improved management of type 2 diabetes Reduced risk of cardiovascular events Potential savings in long-term healthcare costs Drawbacks and Concerns High cost: These drugs can cost over $1,000 per month without insurance Side effects: Nausea, vomiting, and gastrointestinal issues are common Long-term effects are still being studied Increased demand leading to drug shortages Impact on Health Insurance Premiums The rising popularity of GLP-1 drugs is affecting health insurance premiums: Some insurers report large double digit increases in pharmacy costs due to GLP-1 prescriptions This could lead to higher premiums for all policyholders However, long-term savings from reduced obesity-related health issues could offset these increases the data is still not comprehensive enough Are the Costs Worth It

CrossRef Synbiotics and antioxidants synergistically attenuate disease progression in metabolic dysfunction-associated steatotic liver disease Zhilu Xu, Wenyi Zhu, Qiyun Xia, Wenli Huang, Yuanyuan Chi, Haoyu Qi, Oi Yee Pessy Chan, Jessica YL Ching, Francis KL Chan, Nor Norman Chan, Siew C